Figure 1.
Enrollment of study participants. Of 85 patients with IgGSD, 45 met the inclusion criteria of the study: no known severe lung disease (FEV1% <40) and no previous discontinuation trial. 35 accepted to participate in the study and started IgGRT within the time frame of the study. Samples for analysis of pneumococcal SSA were available from 28 of the 35 patients who started IgGRT.

Enrollment of study participants. Of 85 patients with IgGSD, 45 met the inclusion criteria of the study: no known severe lung disease (FEV1% <40) and no previous discontinuation trial. 35 accepted to participate in the study and started IgGRT within the time frame of the study. Samples for analysis of pneumococcal SSA were available from 28 of the 35 patients who started IgGRT.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal